Mannkind (MNKD) Current Assets (2010 - 2026)
Mannkind (MNKD) reported Current Assets of $251.2 million for Q1 2026, down 8.25% year-over-year from $273.7 million in Q1 2025, and down 13.86% on a QoQ basis from $291.6 million in Q4 2025.
Mannkind (MNKD) has 17 years of Current Assets data on file, last reported at $251.2 million in Q1 2026.
- Quarterly Current Assets fell 8.25% year-over-year to $251.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $251.2 million (down 8.25% YoY) and the FY2025 annual result came in at $291.6 million, up 8.67% from the prior year.
- Current Assets declined to $251.2 million in Q1 2026 per MNKD's latest filing, from $291.6 million in the prior quarter.
- Across five years, Current Assets topped out at $383.1 million in Q1 2024 and bottomed at $184.3 million in Q1 2022.
- The 5-year median for Current Assets is $268.3 million (2024), against an average of $273.1 million.
- The widest annual swing landed in 2022, when Current Assets sank 36.09%; it then jumped 71.56% in 2024.
- Tracing MNKD's Current Assets over 5 years: stood at $234.9 million in 2022, then surged by 58.96% to $373.4 million in 2023, then dropped by 28.14% to $268.3 million in 2024, then grew by 8.67% to $291.6 million in 2025, then fell by 13.86% to $251.2 million in 2026.
- Per Business Quant, the three latest MNKD Current Assets figures stand at $251.2 million (Q1 2026), $291.6 million (Q4 2025), and $358.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 251.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251.16 Mn |
| Dec 31, 2025 | 291.58 Mn |
| Sep 30, 2025 | 358.84 Mn |
| Jun 30, 2025 | 279.03 Mn |
| Mar 31, 2025 | 273.74 Mn |
| Dec 31, 2024 | 268.31 Mn |
| Sep 30, 2024 | 327.66 Mn |
| Jun 30, 2024 | 325.94 Mn |
| Mar 31, 2024 | 383.10 Mn |
| Dec 31, 2023 | 373.39 Mn |
| Sep 30, 2023 | 225.58 Mn |
| Jun 30, 2023 | 230.23 Mn |
| Mar 31, 2023 | 223.30 Mn |
| Dec 31, 2022 | 234.90 Mn |
| Sep 30, 2022 | 218.38 Mn |
| Jun 30, 2022 | 193.48 Mn |
| Mar 31, 2022 | 184.27 Mn |
| Dec 31, 2021 | 219.49 Mn |
| Sep 30, 2021 | 159.21 Mn |
| Jun 30, 2021 | 179.90 Mn |
| Mar 31, 2021 | 288.34 Mn |
| Dec 31, 2020 | 79.48 Mn |
| Sep 30, 2020 | 66.35 Mn |
| Jun 30, 2020 | 72.58 Mn |
| Mar 31, 2020 | 49.35 Mn |
| Dec 31, 2019 | 60.76 Mn |
| Sep 30, 2019 | 61.74 Mn |
| Jun 30, 2019 | 49.83 Mn |
| Mar 31, 2019 | 69.69 Mn |
| Dec 31, 2018 | 81.85 Mn |
| Sep 30, 2018 | 19.53 Mn |
| Jun 30, 2018 | 35.80 Mn |
| Mar 31, 2018 | 35.03 Mn |
| Dec 31, 2017 | 57.22 Mn |
| Sep 30, 2017 | 28.63 Mn |
| Jun 30, 2017 | 50.93 Mn |
| Mar 31, 2017 | 56.09 Mn |
| Dec 31, 2016 | 77.49 Mn |
| Sep 30, 2016 | 48.60 Mn |
| Jun 30, 2016 | 90.76 Mn |
| Mar 31, 2016 | 44.14 Mn |
| Dec 31, 2015 | 76.65 Mn |
| Sep 30, 2015 | 71.24 Mn |
| Jun 30, 2015 | 145.83 Mn |
| Mar 31, 2015 | 158.29 Mn |
| Dec 31, 2014 | 201.15 Mn |
| Sep 30, 2014 | 193.52 Mn |
| Jun 30, 2014 | 44.91 Mn |
| Mar 31, 2014 | 39.40 Mn |
| Dec 31, 2013 | 76.28 Mn |
| Sep 30, 2013 | 99.33 Mn |
| Jun 30, 2013 | 32.16 Mn |
| Mar 31, 2013 | 32.29 Mn |
| Dec 31, 2012 | 66.81 Mn |
| Sep 30, 2012 | 23.20 Mn |
| Jun 30, 2012 | 50.35 Mn |
| Mar 31, 2012 | 59.71 Mn |
| Dec 31, 2011 | 5.82 Mn |
| Sep 30, 2011 | 27.02 Mn |
| Jun 30, 2011 | 26.86 Mn |
| Dec 31, 2010 | 73.95 Mn |